Ç×°¨¿°Á¦ ½ÃÀå : À¯Çüº°, Åõ¿© °æ·Îº°, À¯Åë ä³Îº°, Áö¿ªº°(2025-2033³â)
Anti-infectives Market Report by Type, Route of Administration (Topical, Oral, Intravenous, and Others), Distribution Channel, and Region 2025-2033
»óǰÄÚµå : 1702038
¸®¼­Ä¡»ç : IMARC Group
¹ßÇàÀÏ : 2025³â 04¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 136 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,154,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,539,000
PDF & Excel (5 User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 6,925,000
PDF & Excel (Corporate License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Ç×°¨¿°Á¦ ½ÃÀå ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â 1,388¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2033³â¿¡´Â 1,800¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óÇϸç, 2025-2033³â ¿¬Æò±Õ ¼ºÀå·ü(CAGR)Àº 2.93%¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇÕ´Ï´Ù.

Ç×°¨¿°Á¦´Â °¨¿°ÁõÀÇ È®»êÀ» ¾ïÁ¦Çϰųª °¨¿° ÀÎÀÚ¸¦ ¿ÏÀüÈ÷ »ç¸ê½ÃÅ´À¸·Î½á °¨¿°Áõ¿¡ ÀÛ¿ëÇÏ´Â ÀǾàǰÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÀǾàǰ¿¡´Â Ç×»ýÁ¦, Ç×¹ÙÀÌ·¯½ºÁ¦, Ç×Áø±ÕÁ¦, Ç׸»¶ó¸®¾ÆÁ¦, ±¸ÃæÁ¦, Ç׿øÃæÁ¦ µîÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ¾à¹°Àº ÀϹÝÀûÀ¸·Î °æ±¸, ºñ°æ±¸, ±¹¼ÒÀûÀ¸·Î Åõ¿©µË´Ï´Ù. Æó·Å°ú °áÇÙÀ» Æ÷ÇÔÇÑ °æ¹ÌÇÑ °¨¿°¼º ÁúȯÀÇ Ä¡·á¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¦¿ÕÀý°³³ª Àΰø°üÀý ġȯ¼ú°ú °°ÀÌ ½É°¢ÇÑ °¨¿°ÀÇ À§ÇèÀÌ ³ôÀº ÀÏ»óÀûÀÎ ½Ã¼úÀ̳ª ¼ö¼ú ½Ã¿¡µµ »ç¿ëµË´Ï´Ù.

Ç×°¨¿°Á¦ ½ÃÀå µ¿Çâ:

¼¼°è Ç×°¨¿°Á¦ ½ÃÀåÀÇ ÁÖ¿ä ¿øµ¿·ÂÀº Àü ¼¼°èÀûÀ¸·Î °¨¿°¼º ÁúȯÀÌ Áõ°¡Çϰí ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. Ç×°¨¿°Á¦´Â ¹ÙÀÌ·¯½º, ¹ÚÅ׸®¾Æ, ±â»ýÃæ, °õÆÎÀ̸¦ Æ÷ÇÔÇÑ °¨¿°¼º ÁúȯÀÇ Ä¡·á¿¡ »ç¿ëµË´Ï´Ù. ¶ÇÇÑ, õ¿¬¹°, Äõ¶÷¼¾½Ì ¾ïÁ¦Á¦, ¹ÙÀÌ¿ÀÇʸ§ ÆÄ±«Á¦, °¥·ý ±â¹Ý ¾à¹°, »çÀÌŬ·Îµ¦½ºÆ®¸° ¾ïÁ¦Á¦, ±¤±â¹Ý Ç×±ÕÁ¦ µî ´Ù¾çÇÑ Àü·«À¸·Î Á¦ÇüÈ­µÈ ½Å±Ô ¾à¹°ÀÇ °³¹ßÀÌ ½ÃÀå °³Ã´¿¡ ź·ÂÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ÀÌ¿Í ÇÔ²² Áٱ⼼Æ÷ ¹× OOC(Organ On Chip) ±â¼ú µî ½Å¾à°³¹ß ÀýÂ÷ÀÇ Ãֽбâ¼ú Çõ½ÅÀº ½Å¾à°³¹ß ½ÃÇè °úÁ¤À» °­È­ÇÏ¿© ½ÃÀå¿¡ ¹àÀº Àü¸ÁÀ» °¡Á®´ÙÁÖ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾Æ½ºÆä¸£±æ·ç½ºÁõ, ħ½À¼º Ä­µð´ÙÁõ, Á¡±ÕÁõ°ú °°Àº COVID-19 Áúȯ ¹× À¯¹ß¼º °¨¿°ÁõÀÇ ÃâÇöÀ¸·Î ÀÎÇÑ Á¦Ç° äÅà Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» °­È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ¿Í ´õºÒ¾î, ±ÔÁ¦ ´ç±¹ÀÌ ½ÂÀÎÇÏ´Â »õ·Î¿î Ç×°¨¿° ¾à¹°ÀÇ ¼ö°¡ Áõ°¡Çϰí ÀÖ´Â °Íµµ ¼ºÀåÀ» ÃËÁøÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, À¯¸®ÇÑ Á¤ºÎ Á¤Ã¥ÀÇ ½ÃÇà, Çõ½ÅÀûÀÎ ½Å¾à °³¹ß¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, °¨¿°¼º Áúȯ¿¡ ´ëÇÑ °³ÀÎÀÇ ÀÎ½Ä Áõ°¡, ÀÇ·á ÀÎÇÁ¶óÀÇ ±Þ¼ÓÇÑ °³¼± µîÀÌ ÇâÈÄ ¸î ³â µ¿¾È ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

Á¦5Àå ¼¼°èÀÇ Ç×°¨¿°Á¦ ½ÃÀå

Á¦6Àå ½ÃÀå ³»¿ª : À¯Çüº°

Á¦7Àå ½ÃÀå ³»¿ª : Åõ¿© °æ·Îº°

Á¦8Àå ½ÃÀå ³»¿ª : À¯Åë ä³Îº°

Á¦9Àå ½ÃÀå ³»¿ª : Áö¿ªº°

Á¦10Àå SWOT ºÐ¼®

Á¦11Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦12Àå Porter's Five Forces ºÐ¼®

Á¦13Àå °¡°Ý ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global anti-infectives market size reached USD 138.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 180.0 Billion by 2033, exhibiting a growth rate (CAGR) of 2.93% during 2025-2033.

Anti-infectives are medicines that act against infections, either by inhibiting the spread or killing the infectious agent outright. These medicines include antibiotics, antivirals, antifungals, antimalarials, anthelmintics, and antiprotozoals. They are generally administered through oral, parenteral, and topical routes. They are widely used to treat minor infectious diseases, including pneumonia and tuberculosis. Apart from this, anti-infectives are also utilized during routine procedures and surgeries, such as cesarian section and joint replacement, which are associated with a high risk of severe infection.

Anti-infectives Market Trends:

The global anti-infectives market is primarily driven by rising incidences of infectious diseases across the globe. Anti-Infinitives are used to treat infections, including viruses, bacteria, parasites, and fungi. Additionally, the development of novel drugs that are formulated using different strategies, such as natural products, quorum sensing inhibitors, biofilm disruptors, gallium-based drugs, cyclodextrin inhibitors, and light-based antimicrobials, are providing an impetus to the market growth. In line with this, the latest innovations in drug discovery procedures, such as stem cells and organ-on-chip (OOC) technologies, to enhance drug trial processes are creating a positive outlook for the market. Furthermore, the increasing product adoption due to the advent of the COVID-19 disease and induced infections, such as aspergillosis, invasive candidiasis, and mucormycosis, is strengthening the growth of the market. Besides this, the increasing number of new anti-infective drugs being approved by the regulatory authorities is acting as another growth-inducing factor. Moreover, the implementation of favorable government policies, rising investments in developing new and innovative drugs, increasing awareness among individuals about infectious diseases, and rapidly improving healthcare infrastructure are anticipated to impel the growth of the market in the coming years.

Key Market Segmentation:

Breakup by Type:

Breakup by Route of Administration:

Breakup by Distribution Channel:

Breakup by Region:

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Cipla Health Ltd. (Cipla Limited), F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, Johnson & Johnson, Lupin Limited, Sandoz AG (Novartis AG) and Sun Pharmaceutical Industries Limited.

Key Questions Answered in This Report

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Anti-infectives Market

6 Market Breakup by Type

7 Market Breakup by Route of Administration

8 Market Breakup by Distribution Channel

9 Market Breakup by Region

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Analysis

14 Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â